ENT-EAR NOSE & THROAT JOURNAL is a leading platform for the dissemination of high-quality research and clinical insights in the field of otorhinolaryngology and related medical specialties. Published by SAGE PUBLICATIONS INC, the journal has established its significance within the academic community, evidenced by its Q3 ranking in both the Medicine (miscellaneous) and Otorhinolaryngology categories as of 2023, alongside a Scopus rank of #47 out of 123. Since its transition to Open Access in 2019, the journal has further broadened its reach, allowing researchers, professionals, and students to access a wealth of knowledge without financial barriers. With a continual focus on innovative findings and clinical practices from 1976 to 2024, ENT-EAR NOSE & THROAT JOURNAL aims to foster collaboration and enhance understanding in the multifaceted realm of ear, nose, and throat disorders, making it an invaluable resource in both academia and clinical practice. The journal is based in the United States, with its headquarters located at 2455 Teller Rd, Thousand Oaks, CA 91320.

OTO Open is a distinguished peer-reviewed journal published by WILEY, dedicated to the field of Otorhinolaryngology and its associated surgical disciplines. Since its inception in 2017, it has established itself as an Open Access platform, ensuring that groundbreaking research is accessible to a global audience. With a notable impact factor reflecting its relevance, OTO Open ranks in the top quartiles for both Otorhinolaryngology (Q1) and Surgery (Q2) as of 2023, showcasing its influential contributions to the medical community. The journal is indexed in Scopus, holding a significant position in both the Medicine & Surgery and Medicine & Otorhinolaryngology categories. Spanning years from 2017 to 2024, OTO Open serves as a critical resource for researchers, professionals, and students alike, promoting innovative insights and advancements in the field. The journal is based in the United States, at 111 River St, Hoboken, NJ, and looks forward to continuing its mission of advancing knowledge and research in otorhinolaryngology.

Chirurgia-Italy, an esteemed publication in the field of Surgery, is published by EDIZIONI MINERVA MEDICA. Since its inception in 1973, it has become a platform for disseminating significant findings and advancements in surgical practice, evidenced by its continuous publication history through various converged years up until 2024. Although currently classified in the Q4 category of surgery journals in 2023, and ranking within the 3rd percentile in Scopus with respect to medicine and surgery, its role in enriching the surgical community with critical insights remains vital. Researchers, practitioners, and students alike will find valuable information and discussions pertinent to contemporary surgical techniques and methodologies. While the journal does not operate under an open access model, its content is nonetheless indispensable for those looking to stay informed about the latest developments in the surgical landscape.

COLOPROCTOLOGY is a specialized journal published by Springer, dedicated to advancing knowledge and understanding in the fields of Gastroenterology and Surgery. With an ISSN of 0174-2442 and an E-ISSN of 1615-6730, this journal holds a prominent position in the medical literature, despite being categorized in the Q4 quartile as per the latest metrics for both disciplines. The convergence of research published from 1998 to 2024 reflects the journal's long-standing commitment to addressing critical issues in coloproctology, offering insights into clinical practices, surgical techniques, and gastrointestinal disorders. While the journal does not currently provide open access options, it remains a vital resource for professionals, researchers, and students aiming to enhance their understanding of complex gastrointestinal health challenges. With its esteemed publisher, Springer, COLOPROCTOLOGY aims to foster innovation and scholarly dialogue within the medical community.

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.

ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

AURIS NASUS LARYNX, published by Elsevier Science Ltd, is a leading peer-reviewed journal specializing in the fields of otorhinolaryngology, surgery, and general medicine. Since its inception in 1974, this esteemed journal has been committed to disseminating high-quality research and innovative findings pertinent to the diagnosis, treatment, and management of ear, nose, and throat diseases. With an impressive 2023 impact factor reflected in its Q2 quartile rankings in both Medicine (miscellaneous) and Otorhinolaryngology, as well as its strong position in Surgery, AURIS NASUS LARYNX is regarded highly among researchers and practitioners. The journal is accessible through a subscription model, ensuring that essential knowledge remains within reach for both clinical and academic pursuits. The continuous evolution of its content promises to stay at the forefront of medical advancements, making it an invaluable resource for scholars, clinicians, and students striving for excellence in the medical field.

Welcome to the Australian Journal of Otolaryngology, a premier resource in the field of Otorhinolaryngology, published by AME Publishing Company. Established in 2018, this journal continues to be a vital platform for disseminating groundbreaking research and advancements in ear, nose, and throat medicine. With its commitment to open access, the journal strives to ensure that high-quality research is widely available to practitioners, researchers, and students alike. Positioned in the Q3 category for Otorhinolaryngology as of 2023, the journal is ranked #94 out of 123 in Scopus, indicating its increasing recognition in the academic community. The editorial board comprises distinguished experts dedicated to enhancing the understanding of otolaryngological disorders and treatments. We invite you to explore the latest findings and contribute to the growth of this dynamic field through your submissions.